Sequential cytotoxicity: a theory evaluated using novel 2-[4-(3-aryl-2-propenoyloxy)phenylmethylene]cyclohexanones

J R Dimmock1, N M Kandepu, A J Nazarali

  • 1College of Pharmacy and Nutrition and Departments of Biochemistry and Chemistry, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5C9, Canada. dimmock@skyway.usask.ca

Insights

Novel compounds were synthesized to test sequential cytotoxicity theory in cancer cells. Some Mannich bases showed significant potency and selective toxicity, warranting further development as potential anti-cancer agents.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Computational Chemistry

Background:

  • Cancer cells may be susceptible to sequential attacks by cytotoxic agents.
  • Novel compounds were designed to investigate this sequential cytotoxicity theory.
  • Understanding drug interactions with cellular components is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To synthesize and evaluate novel compounds based on the sequential cytotoxicity theory.
  • To assess the cytotoxic effects of synthesized compounds against various cancer cell lines.
  • To explore the potential of Mannich bases as lead molecules for anti-cancer drug development.

Main Methods:

  • Synthesis of five series of novel compounds, including cyclohexanones and Mannich bases.
  • Molecular modeling calculations to determine atomic charges at interaction sites.
  • In vitro biological evaluation using murine and human neoplastic cells.

Main Results:

  • The sequential cytotoxicity theory was supported in approximately two-thirds of the tested cases.
  • Some Mannich bases demonstrated significant potency against human tumor cell lines.
  • Selective toxicity was observed in human leukemic and colon cancer cells for certain Mannich bases.
  • Compounds were found to induce apoptosis and inhibit RNA and protein biosynthesis.

Conclusions:

  • The sequential cytotoxicity hypothesis warrants further investigation.
  • Certain Mannich bases show promise as lead compounds for developing new anti-cancer drugs.
  • The identified compounds exhibit anti-cancer properties through apoptosis induction and inhibition of essential biosynthetic pathways.

Related Concept Videos